The origins and evolution of "controlled" drug delivery systems.
about
Nanocarriers Usage for Drug Delivery in Cancer TherapyTiO2 nanotube platforms for smart drug delivery: a reviewIn vitro-in vivo correlation for complex non-oral drug products: Where do we stand?Fabricated ElastinReversion of pH-induced physiological drug resistance: a novel function of copolymeric nanoparticlesAffinity-Based Drug DeliveryBiomedical Imaging in Implantable Drug Delivery Systems.3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.Drug delivery to the posterior segment of the eye for pharmacologic therapy.Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriersAtomically precise organomimetic cluster nanomolecules assembled via perfluoroaryl-thiol SNAr chemistryNear infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy.Hydration-induced phase separation in amphiphilic polymer matrices and its influence on voclosporin releasePolymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.Surface functionalization of nanoparticles for nanomedicine.Specific tumor delivery of paclitaxel using glycolipid-like polymer micelles containing gold nanospheresBioreducible polymers for therapeutic gene deliveryCombination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.Nanoparticles of esterified polymalic acid for controlled anticancer drug release.Shining light on nanotechnology to help repair and regeneration.NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriersBiodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus.Transdermal patches: history, development and pharmacology.DOX-Cu9S5@mSiO2-PG composite fibers for orthotopic synergistic chemo- and photothermal tumor therapy.Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.Multifunctional Nd(3+)-sensitized upconversion nanomaterials for synchronous tumor diagnosis and treatment.Degradability of poly(lactic acid)-containing nanoparticles: enzymatic access through a cross-linked shell barrier.Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression.EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies.Engaging neuroscience to advance translational research in brain barrier biology.Externally controlled drug release using a gold nanorod contained composite membrane.Multi-layer polymeric implants for sustained release of chemopreventives.Challenges in design and characterization of ligand-targeted drug delivery systems.Vaginal rings for delivery of HIV microbicides.Advanced materials and processing for drug delivery: the past and the future.Using the Power of Organic Synthesis for Engineering the Interactions of Nanoparticles with Biological Systems.Nanoparticle characterization: state of the art, challenges, and emerging technologies.
P2860
Q26740048-DE3990E2-1DFC-4A1C-B9BB-CC923218E564Q28066800-0C958FA6-6D67-4BDD-8AC5-D21AB1D1431DQ28080736-2097FF29-819B-4BB3-BDEE-129034F768BCQ28087162-C866C39B-E341-45BC-AAAD-E452C5AAB505Q28477221-C74C6BFF-8DB5-41C9-ACB7-9BA99E8C9A6CQ29543246-D39DA0D8-3F9C-4FAC-AA4A-E28748995B86Q30394673-A9BA9C86-B8D7-4DF4-953C-9E9927E08B74Q30444900-642DC5E7-C376-46D2-A1EF-63781CCA01CCQ30478379-1FBD0174-AB30-42FB-A1CF-FA2F1B23AC3DQ30546346-5BE24CBA-FD5C-4352-AE29-934CA3917DC1Q30848309-57D07F4E-C36D-4961-96C3-57B41C0F625CQ33578775-86AE61FE-C89F-4D92-9B4D-11E978AB8EE7Q33649720-173943EC-E578-475A-A757-52C03305F440Q33653191-6E71C35A-CF4E-4827-94F4-2AC4159BB50CQ33902253-A531FF7C-33B0-4125-B968-78A216619A3FQ33908425-13B6662B-7EB9-4F83-AA58-2EFC8459939AQ33915941-65CA6D51-D327-4422-8619-574C0D4A09B3Q33937209-8C8A9AF2-C3C0-4842-82F5-83A24BD9ABB6Q34079568-28292947-B043-4C5A-B29B-B944F9844011Q34119423-5CB445E3-1CD5-4A7D-B12F-95D01375A54DQ34156543-F106CEC1-4CF8-4384-B4F9-98CC84B74572Q34404413-D9C32BE7-9522-4EF1-A308-E30B86DDC52EQ34534023-EAC8537C-9036-4639-8D20-C6708087A1D7Q34690444-8A5EC5E4-07DE-4EC7-A967-56AE72B5E454Q35002405-4954A217-5BC4-47B0-964B-86221D0C23D8Q35484265-7DB2BD5C-1B36-4652-9DDB-C7CF6FBF8780Q35539524-86E73B5E-00BC-4F8C-8759-DBF5ED496869Q35577222-6C9D98F4-B3AE-49C2-B86B-3A12E5DB256FQ35610814-CAC2B5E0-F02E-4E92-BE7D-BAB743A8A097Q35691444-CC14C251-73E3-40AB-972F-6CDF45C9D7ECQ35819114-3D32CE56-27EC-41F8-951E-48AC5E2FAFE3Q35851952-EB64959A-5CEE-436D-BA0F-4DC92179273DQ35909313-002D5DC2-A63F-43E6-895E-9596B67B84AEQ36033998-D3C40F96-F161-427C-933A-929BA82B568AQ36292750-9BD672C7-76E7-4948-B8E9-37EC274247F0Q36346851-7D5F9A83-1000-468F-A9DC-8141DD65E433Q36429890-78B079CF-B17D-429D-B302-4467C46918D7Q36589333-0D31D1C7-0C5D-4837-969C-68F204415BF9Q36844202-8878393B-1D99-4870-8C8E-8CB3672A64D1Q36901928-910ECB62-497C-4989-8C97-E7C048BDE1E0
P2860
The origins and evolution of "controlled" drug delivery systems.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The origins and evolution of "controlled" drug delivery systems.
@en
The origins and evolution of "controlled" drug delivery systems.
@nl
type
label
The origins and evolution of "controlled" drug delivery systems.
@en
The origins and evolution of "controlled" drug delivery systems.
@nl
prefLabel
The origins and evolution of "controlled" drug delivery systems.
@en
The origins and evolution of "controlled" drug delivery systems.
@nl
P1476
The origins and evolution of "controlled" drug delivery systems.
@en
P2093
Allan S Hoffman
P304
P356
10.1016/J.JCONREL.2008.08.012
P407
P577
2008-08-28T00:00:00Z